Short-term effects of morning versus evening dose of hydroxyzine 50 mg on cognition in healthy volunteers

Journal of Clinical Psychopharmacology

Volumn 31, Issue 3, 2011, Pages 294-301

  Conen, Silke ^a   Theunissen, Eef L ^a   Vermeeren, Annemiek ^a   Ramaekers, Johannes G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

cognition; H1 antagonists; hydroxyzine; sleep

Indexed keywords

ANTIHISTAMINIC AGENT; HYDROXYZINE; PLACEBO;

ADULT; AROUSAL; ARTICLE; ATTENTION; ATTENTION NETWORK TEST; COGNITION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIVIDED ATTENTION TASK; DOSAGE SCHEDULE COMPARISON; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG HALF LIFE; EVENING DOSAGE; EXPERIMENTAL ATTENTION SWITCH TASK; FEMALE; HUMAN; HUMAN EXPERIMENT; IMPULSIVENESS; MALE; MORNING DOSAGE; NORMAL HUMAN; PERCEPTION; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; SEDATION; STOP SIGNAL TASK; TASK PERFORMANCE;

ADULT; ATTENTION; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYDROXYZINE; IMPULSIVE BEHAVIOR; MALE; PSYCHOMOTOR PERFORMANCE; REACTION TIME;

EID: 79955574279     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318218943c     Document Type: Article

References (56)

1. Theunissen EL, Vermeeren A, Ramaekers JG. Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance. Br J Clin Pharmacol. 2006;61(1):79-86. (Pubitemid 43381240)
2. Vuurman EF, Rikken GH, Muntjewerff ND, et al. Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements. Eur J Clin Pharmacol. 2004;60(5):307-313. (Pubitemid 39062317)
3. Kay GG. The effects of antihistamines on cognition and performance. J Allergy Clin Immunol. 2000;105(6 Pt 2):S622-S627. (Pubitemid 30399797)
4. Tashiro M, Horikawa E, Mochizuki H, et al. Effects of fexofenadine and hydroxyzine on brake reaction time during car-driving with cellular phone use. Hum Psychopharmacol. 2005;20(7):501-509. (Pubitemid 41489462)
5. Montoro J, Sastre J, Bartra J, et al. Effect of H1 antihistamines upon the central nervous system. J Investig Allergol Clin Immunol. 2006;16(suppl 1):24-28. (Pubitemid 46057827)
6. Tashiro M, Duan X, Kato M, et al. Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin. Br J Clin Pharmacol. 2008;65(6):811-821. (Pubitemid 351695231)
7. Van Ruitenbeek P, Vermeeren A, Riedel WJ. Histamine H1-receptor blockade in humans affects psychomotor performance but not memory. J Psychopharmacol. 2008;22:663-672.
8. Jauregui I, Mullol J, Bartra J, et al. H1 antihistamines: psychomotor performance and driving. J Investig Allergol Clin Immunol. 2006; 16(suppl 1):37-44.
9. Ramaekers JG, O'Hanlon JF. Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing. Eur J Clin Pharmacol. 1994;47(3):261-266. (Pubitemid 24330668)
10. Vermeeren A, Ramaekers JG, O'Hanlon JF. Effects of emedastine and cetirizine, alone and with alcohol, on actual driving of males and females. J Psychopharmacol. 2002;16(1):57-64. (Pubitemid 34273074)
11. Verster JC, Volkerts ER. Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic. Ann Allergy Asthma Immunol. 2004;92(3):294-303; quiz 303-305, 355.
12. Quach TT, Duchemin AM, Rose C, et al. In vivo occupation of cerebral histamine H1-receptors evaluated with 3H-mepyramine may predict sedative properties of psychotropic drugs. Eur J Pharmacol. 1979;60(4):391-392. (Pubitemid 10168550)
13. Roehrs T, Claiborue D, Knox M, et al. Effects of ethanol, diphenhydramine, and triazolam after a nap. Neuropsychopharmacology. 1993;9(3):239-245. (Pubitemid 23324324)
14. Ramaekers JG, Muntjewerff ND, Van Veggel LMA, et al. Effects of nocturnal doses of mirtazapine and mianserin on sleep and on daytime psychomotor and driving performance in young, healthy volunteers. Hum Psychopharmacol. 1998;13:S87-S97. (Pubitemid 28512913)
15. Ramaekers JG, Swijgman HF, O'Hanlon JF. Effects of moclobemide and mianserin on highway driving, psychometric performance and subjective parameters, relative to placebo. Psychopharmacology (Berl). 1992;106(suppl):S62- S67.
16. Vermeeren A, Ramaekers G, Van Leeuwen CJ, et al. Residual effects on actual car driving of evening dosing of chlorpheniramine 8 and 12 mg when used with terfenadine in the morning. Hum Psychopharmacol. 1998;13:S79-S86. (Pubitemid 28512912)
17. Wingen M, Bothmer J, Langer S, et al. Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial. J Clin Psychiatry. 2005;66(4):436-443. (Pubitemid 40593571)
18. Haas HL, Reiner PB. Membrane properties of histaminergic tuberomammillary neurones of the rat hypothalamus in vitro. J Physiol. 1988;399:633-646.
19. Reiner PB, Heimrich B, Keller F, et al. Organotypic culture of central histamine neurons. Brain Res. 1988;442(1):166-170. (Pubitemid 18065753)
20. Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Prog Neurobiol. 2001;63(6):637-672. (Pubitemid 32119421)
21. Tuomisto L, Lozeva V, Valjakka A, et al. Modifying effects of histamine on circadian rhythms and neuronal excitability. Behav Brain Sci. 2001;124(2):129-135. (Pubitemid 32964630)
22. Sakai K, Mansari M, Lin JS, et al. The posterior hypothalamus in the regulation of wakefulness and paradoxical sleep. In: Mancia M, Marini M, eds. The Diencephalon and Sleep. New York, NY: Raven; 1990.
23. Schwartz JC, Arrang JM, Garbarg M, et al. Histamine. In: Blomm FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven; 1994:397-405.
24. Vanni-Mercier G, Gigout S, Debilly G, et al. Waking selective neurons in the posterior hypothalamus and their response to histamine H3-receptor ligands: an electrophysiological study in freely moving cats. Behav Brain Res. 2003;144(1-2):227-241. (Pubitemid 37011182)
25. Huang ZL, Mochizuki T, Qu WM, et al. Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice. Proc Natl Acad Sci USA. 2006;103(12):4687-4692.
26. Ko EM, Estabrooke IV, McCarthy M, et al. Wake-related activity of tuberomammillary neurons in rats. Brain Res. 2003;992(2):220-226. (Pubitemid 37415104)
27. Seidel WF, Cohen S, Bliwise NG, et al. Direct measurement of daytime sleepiness after administration of cetirizine and hydroxyzine with a standardized electroencephalographic assessment. J Allergy Clin Immunol. 1990;86(6 Pt 2):1029-1033.
28. Theunissen EL, Vermeeren A, van Oers AC, et al. A dose-ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo. Clin Exp Allergy. 2004;34(2):250-258. (Pubitemid 38315262)
29. Verster JC, Volkerts ER, van Oosterwijck AW, et al. Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood. J Allergy Clin Immunol. 2003;111(3):623-627. (Pubitemid 36337888)
30. Kerkhof GA. Een Nederlandse vragenlijst voor de selectie van ochtend-en avondmensen. (A Dutch questionnaire for the selection of morning and evening type individuals). Nederlands tijdschrift voor de psychologie. 1984;39:281-294.
31. del Cuvillo A, Mullol J, Bartra J, et al. Comparative pharmacology of the H1 antihistamines. J Investig Allergol Clin Immunol. 2006; 16(suppl 1):3-12.
32. Simons FE, Simons KJ, Frith EM. The pharmacokinetics and antihistaminic of the H1 receptor antagonist hydroxyzine. J Allergy Clin Immunol. 1984;73(1 Pt 1):69-75. (Pubitemid 14185124)
33. Conen S, Theunissen EL, Van Oers AC, et al. Acute and subchronic effects of bilastine (20 and 40 mg) and hydroxyzine (50 mg) on actual driving performance in healthy volunteers. Journal of Psychopharmacology. September 2010. Available at: http:// jop.sagepub.com/content/early/2010/09/18/ 0269881110382467.long. Accessed September 10, 2010.
34. Vuurman E, Theunissen E, van Oers A, et al. Lack of effects between rupatadine 10 mg and placebo on actual driving performance of healthy volunteers. Hum Psychopharmacol. 2007;22(5):289-297. (Pubitemid 47180390)
35. Jex HR, McDonnell JD, Phatak AV. A "critical" tracking task for man-machine research related to the operator's effective delay time. I. Theory and experiments with a first-order divergent controlled element. NASA CR-616. NASA Contractor Report NASA CR. 1966;1-105.
36. Moskowitz H. Laboratory studies of the effects of alcohol on some variables related to driving. J Safety Res. 1973;5:185-192.
37. Theunissen EL, Jonkman LM, Kuypers KPC, et al. Stimulating effects of fexofenadine under high workload conditions. A combined neurophysiological and behavioral approach. J Psychopharmacol. 2006;20:485-495.
38. Fan J, McCandliss BD, Fossella J, et al. The activation of attentional networks. Neuroimage. 2005;26(2):471-479. (Pubitemid 40719825)
39. Fan J, McCandliss BD, Sommer T, et al. Testing the efficiency and independence of attentional networks. J Cogn Neurosci. 2002; 14(3):340-347. (Pubitemid 34267537)
40. Fan J, Byrne J, Worden MS, et al. The relation of brain oscillations to attentional networks. J Neurosci. 2007;27(23):6197-6206. (Pubitemid 46890026)
41. Ramaekers JG, Kuypers KP. Acute effects of 3,4- methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol. Neuropsychopharmacology. 2006;31(5):1048-1055.
42. Theunissen EL, van Kroonenburgh MJ, van Deursen JA, et al. Stimulating effects of fexofenadine: testing the dopamine transporter hypothesis. Psychopharmacology. 2006;187(1):95-102. (Pubitemid 43876921)
43. Markus CR, Jonkman LM. Attention switching after dietary brain 5-HT challenge in high impulsive subjects. J Psychopharmacol. 2007;21(7):700-708. (Pubitemid 47437919)
44. Mulder-Hajonides van der Meulen WREH. Measurements of subjective sleep quality. In: Proceedings of International European Sleep Congress; 1981. Amsterdam, The Netherlands: Elsevier; 1981.
45. Bond A, Lader M. The use of analogue scales in rating subjective feelings. Br J Med Psychol. 1974;47:211-218.
46. Shete S, Beasley TM, Etzel CJ, et al. Effect of winsorization on power and type 1 error of variance components and related methods of QTL detection. Behav Genet. 2004;34(2):153-159. (Pubitemid 38268932)
47. Tassi P, Muzet A. Sleep inertia. Sleep Med Rev. 2000;4(4):341-353. (Pubitemid 30609982)
48. Akerstedt T. Work hours, sleepiness and the underlying mechanisms. J Sleep Res. 1995;4(S2):15-22.
49. Jewett ME, Wyatt JK, Ritz-De Cecco A, et al. Time course of sleep inertia dissipation in human performance and alertness. J Sleep Res. 1999;8(1):1-8. (Pubitemid 29118870)
50. Wertz AT, Ronda JM, Czeisler CA, et al. Effects of sleep inertia on cognition. JAMA. 2006;295(2):163-164. (Pubitemid 43076432)
51. Baraldo M. The influence of circadian rhythms on the kinetics of drugs in humans. Expert Opin Drug Metab Toxicol. 2008;4(2):175-192. (Pubitemid 351308416)
52. Siegel JM. Clues to the functions of mammalian sleep. Nature. 2005;437(7063):1264-1271. (Pubitemid 41568666)
53. Tagawa M, Kano M, Okamura N, et al. Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine. Br J Clin Pharmacol. 2001;52(5):501-509.
54. Tashiro M, Kato M, Miyake M, et al. Dose dependency of brain histamine H(1) receptor occupancy following oral administration of cetirizine hydrochloride measured using PET with [11C]doxepin. Hum Psychopharmacol. 2009;24(7):540-548.
55. Eagle DM, Baunez C, Hutcheson DM, et al. Stop-signal reaction-time task performance: role of prefrontal cortex and subthalamic nucleus. Cereb Cortex. 2008;18(1):178-188. (Pubitemid 350233064)
56. Ramaekers G, Lamers J, Verhey F, et al. A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and carVfollowing performance in actual traffic. Psychopharmacology (Berl). 2002;159(2):203-210. (Pubitemid 34146565)